Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma.

Subjects

Subjects :

Antineoplastic Agents, Immunological administration & dosage
Antineoplastic Agents, Immunological adverse effects
Cholagogues and Choleretics administration & dosage
Cholangitis, Sclerosing immunology
Cholangitis, Sclerosing therapy
Female
Humans
Liver Function Tests methods
Middle Aged
Neoplasm Staging
Tomography, X-Ray Computed methods
Treatment Outcome
Ursodeoxycholic Acid administration & dosage
Antibodies, Monoclonal, Humanized administration & dosage
Antibodies, Monoclonal, Humanized adverse effects
Glucocorticoids administration & dosage
Hepatitis etiology
Hepatitis immunology
Hepatitis therapy
Melanoma pathology
Melanoma physiopathology
Melanoma therapy
Programmed Cell Death 1 Receptor antagonists & inhibitors
Skin Neoplasms pathology
Skin Neoplasms physiopathology
Skin Neoplasms therapy

Details

Language :

English

ISSN :

1527-3350

Volume :

71

Issue :

6

Database :

MEDLINE

Journal :

Hepatology (Baltimore, Md.)

Publication Type :

Academic Journal

Accession number :

31872447

Full Text :

https://doi.org/10.1002/hep.31089